Akebia Therapeutics, Inc. Annual Depreciation in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Akebia Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
  • Akebia Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $364K, a 8.54% decline year-over-year.
  • Akebia Therapeutics, Inc. annual Depreciation for 2023 was $1.59M, a 4.17% decline from 2022.
  • Akebia Therapeutics, Inc. annual Depreciation for 2022 was $1.65M, a 12.9% decline from 2021.
  • Akebia Therapeutics, Inc. annual Depreciation for 2021 was $1.9M, a 9.52% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.59M -$69K -4.17% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $1.65M -$246K -12.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $1.9M -$200K -9.52% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
2020 $2.1M -$100K -4.55% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
2019 $2.2M +$1.3M +144% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $900K +$300K +50% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $600K +$300K +100% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $300K +$204K +213% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
2015 $96K +$47K +95.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $49K +$48K +4800% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 $1K +$1K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $0 Jan 1, 2012 Dec 31, 2012 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.